inhibitory cytokine il contributes regulatory t-cell function 
regulatory t t-reg cells critical sub-population cd4+ t cells essential maintaining self tolerance preventing autoimmunity limiting chronic inflammatory diseases asthma inflammatory bowel disease regulating homeostatic lymphocyte expansion however also suppress natural immune responses parasites viruses well anti-tumour immunity induced therapeutic vaccines although manipulation t-reg function important goal immunotherapy molecules mediate suppressive activity remain largely unknown demonstrate epstein-barr-virus-induced gene ebi3 encodes il beta interleukin alpha il12a encodes il alpha/p35 highly expressed mouse foxp3+ forkhead box p3 treg cells resting activated effector cd4+ t t-eff cells ebi3-il alpha heterodimer constitutively secreted t-reg t-eff cells ebi3 il12a messenger rna markedly upregulated t-reg cells co-cultured t-eff cells thereby boosting ebi3 il alpha production trans t-reg-cell restriction cytokine occurs ebi3 downstream target foxp3 transcription factor required t-reg-cell development function ebi3-/- il12a-/- t-reg cells significantly reduced regulatory activity vitro fail control homeostatic proliferation cure inflammatory bowel disease vivo phenotypic characteristics distinct il family members novel ebi3-il alpha heterodimeric cytokine designated interleukin il- ectopic expression il confers regulatory activity naive t cells whereas recombinant il suppresses t-cell proliferation taken together data identify il novel inhibitory cytokine may specifically produced t-reg cells required maximal suppressive activity 
